Govt Job: For Ph.D, M.Pharm, M.Sc as Research Associate at AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and postgraduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in postgraduate medical education. 

The institute has comprehensive facilities for teaching, research, and patient care. As provided in the Act, AIIMS conducts teaching programs in medical and para-medical courses both at undergraduate and postgraduate levels and awards its own degrees.

Post : Research Associate – I

Project Title: “A randomized, open-label, parallel-group study to evaluate the safety and efficacy of abrocitinib 100 mg and 200 mg tablets in participants aged 12 years and older with moderate to severe atopic dermatitis in India,” funded by Pfizer.

Project code : N2272
Duration of project : 2 years

Emoluments : As per ICMR guidelines
Place of work : Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi.

Qualifications
i.  Ph.D / MD / MS / MDS OR
ii. MVSc / M.Pharm/ ME / M.Tech having 3 years of research experience with at least one publication in SCI journal

Age Limit : 40 years

Note
1. Only shortlisted candidates will be called for an interview. No TA/DA will be provided.

2. Send your CV with supporting documents in a single PDF file by email at dermatology.aiims12@adarsh

3. Please mention “Application for Research Associate-I in the subject line of the email.

Last date of receiving applications: July 17, till 5 PM.

Related Posts

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

BENGALURU: Sending a strong message against officials who have made it a habit to ignore the applications under Right to Information (RTI) Act, the Karnataka Information Commission has cracked the…

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

New Delhi: The number of drug samples declared as Not of Standard Quality (NSQ) by the drug regulators in the country has registered over two-fold growth during the 12 months of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

Two Gyms In Firozabad Raided, Seize 20 Mephentermine Injections Amid Health Concerns

Two Gyms In Firozabad Raided, Seize 20 Mephentermine Injections Amid Health Concerns

Delhi Drugs Control Department Seizes Insulin Stock Worth Rs 20.06 Lakh

Delhi Drugs Control Department Seizes Insulin Stock Worth Rs 20.06 Lakh

Kerala Health Department Has Launched The MeHEALTH App

Kerala Health Department Has Launched The MeHEALTH App

War Could Affect Up To ₹5,000 Crore Of Pharma Exports And Disrupt Supply Chains

War Could Affect Up To ₹5,000 Crore Of Pharma Exports And Disrupt Supply Chains